Risk of hepatitis B virus (HBV) infection and re-activation after discontinuation of tenofovir and/or lamivudine as part of antiretroviral therapy in a high HBV endemicity setting



Abdullahi, Adam, Beloukas, Apostolos ORCID: 0000-0001-5639-0528, Fopoussi, Olga Mafotsing, Torimiro, Judith, Kouanfack, Charles and Geretti, Anna M ORCID: 0000-0002-3670-6588
(2017) Risk of hepatitis B virus (HBV) infection and re-activation after discontinuation of tenofovir and/or lamivudine as part of antiretroviral therapy in a high HBV endemicity setting. .

[img] Text
AASLD_Abstract_2017.pdf - Accepted Version

Download (79kB)
Item Type: Conference or Workshop Item (Unspecified)
Depositing User: Symplectic Admin
Date Deposited: 21 May 2018 08:24
Last Modified: 13 May 2021 07:10
Related URLs:
URI: https://livrepository.liverpool.ac.uk/id/eprint/3011429